Certis Europe sells business for beneficials in UK, France and Italy to Koppert

Following the decision by Certis Europe to divest itself of its commercial sales business of beneficials in certain European countries, Koppert recently acquired the business for the UK, France and Italy. Certis says it will continue to sell its beneficial organism products elsewhere and develop integrated crop protection programmes for its customers in its other markets.

'The acquisition of Certis Europe’s beneficials sales business in the UK, France and Italy, fits in well with our long-term strategy to further develop biological solutions for these important agricultural and horticultural countries,’ says Koppert Biological Systems’ Managing Director, Henri Oosthoek.

‘The negotiations with Certis were fruitful and coincide with Koppert’s mission to make agriculture healthier, safer and more productive for the better health of people and the planet. The transfer of business is underway and customers in these countries have been notified,’ he added.

For more information:
Koppert Biological Systems
info@koppert.com
www.koppert.com